Screening and Evaluation of Deleterious SNPs in APOE Gene of Alzheimer's Disease

被引:5
|
作者
AhmadMasoodi, Tariq [1 ]
Al Shammari, Sulaiman A. [1 ]
Al-Muammar, May N. [1 ]
Alhamdan, Adel A. [1 ]
机构
[1] King Saud Univ, Coll Appl Med Sci, Dept Community Hlth Sci, POB 11433, Riyadh 11433, Saudi Arabia
关键词
D O I
10.1155/2012/480609
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction. Apolipoprotein E (APOE) is an important risk factor for Alzheimer's disease (AD) and is present in 30-50% of patients who develop late-onset AD. Several single-nucleotide polymorphisms (SNPs) are present in APOE gene which act as the biomarkers for exploring the genetic basis of this disease. The objective of this study is to identify deleterious nsSNPs associated with APOE gene. Methods. The SNPs were retrieved from dbSNP. Using I-Mutant, protein stability change was calculated. The potentially functional nonsynonymous (ns) SNPs and their effect on protein was predicted by PolyPhen and SIFT, respectively. FASTSNP was used for functional analysis and estimation of risk score. The functional impact on the APOE protein was evaluated by using Swiss PDB viewer and NOMAD-Ref server. Results. Six nsSNPs were found to be least stable by I-Mutant 2.0 with DDG value of > -1.0. Four nsSNPs showed a highly deleterious tolerance index score of 0.00. Nine nsSNPs were found to be probably damaging with position-specific independent counts (PSICs) score of = 2.0. Seven nsSNPs were found to be highly polymorphic with a risk score of 3-4. The total energies and root-mean-square deviation (RMSD) values were higher for three mutanttype structures compared to the native modeled structure. Conclusion. We concluded that three nsSNPs, namely, rs11542041, rs11542040, and rs11542034, to be potentially functional polymorphic.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] ApoE genotype in Alzheimer's disease determination
    Ivanusa, P.
    Nadizar, N.
    Fabjan, J.
    Kramberger, M. Gregoric
    Pirtosek, Z.
    Bon, J.
    Rozman, D.
    Paska, A. Videtic
    [J]. FEBS OPEN BIO, 2021, 11 : 199 - 200
  • [32] The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease
    Laws, SM
    Taddei, K
    Martins, G
    Paton, A
    Fisher, C
    Clarnette, R
    Hallmayer, J
    Brooks, WS
    Gandy, SE
    Martins, RN
    [J]. NEUROREPORT, 1999, 10 (04) : 879 - 882
  • [33] A meta-analysis of Alzheimer's disease's relationship with human ApoE gene variants
    Xu, Xiru
    Zhang, Biao
    Wang, Xu
    Zhang, Qing
    Wu, Xiang
    Zhang, Jing
    Bai, Yu
    Gu, Xiaoqun
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 9974 - 9982
  • [34] Screening for mutation of the presenilin 2 gene in Alzheimer's disease
    Isoe, K
    Urakami, K
    Wakutani, Y
    Yong, J
    Adachi, Y
    Nakashima, K
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1997, 8 (01) : 60 - 60
  • [35] Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
    Guojun Bu
    Chia-Chen Liu
    Takahisa Kanekiyo
    [J]. Molecular Neurodegeneration, 8 (Suppl 1)
  • [36] Deleterious Alteration of Glia in the Brain of Alzheimer's Disease
    Kim, Eunyoung
    Otgontenger, Undarmaa
    Jamsranjav, Ariunzaya
    Kim, Sang Seong
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 15
  • [37] Screening and structural evaluation of deleterious Non-Synonymous SNPs of ePHA2 gene involved in susceptibility to cataract formation
    Masoodi, Tariq Ahmad
    Al Shammari, Sulaiman A.
    Al-Muammar, May N.
    Almubrad, Turki M.
    Alhamdan, Adel A.
    [J]. BIOINFORMATION, 2012, 8 (12) : 562 - 567
  • [38] Interaction between the sth and APOE gene polymorphisms modifies risk for Alzheimer's disease
    Seripa, D
    Dal Forno, G
    Matera, MG
    D'Andrea, RP
    Gravina, C
    Masullo, C
    Daniele, A
    Antuono, P
    Wekstein, DR
    Fazio, VM
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S507 - S507
  • [39] Gene therapy in APOE4 homozygote Alzheimer's disease - interim data
    Kaplitt, M.
    Leopold, P.
    Noch, E.
    Ivanidze, J.
    Chazen, J. L.
    Crystal, R.
    Kaminsky, S.
    Bowe, H.
    Wang, M.
    Ballon, D.
    Dyke, J.
    Sondhi, D.
    Gandy, S.
    Giannantoni-Ibelli, G.
    Reha, A.
    Renukuntla, V.
    Barth, J. A.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A12 - A13
  • [40] Correlation between APOE4 gene and gut microbiota in Alzheimer's disease
    Chen, X. -X.
    Zeng, M. -X.
    Cai, D.
    Zhou, H. -H.
    Wang, Y. -J.
    Liu, Z.
    [J]. BENEFICIAL MICROBES, 2023, 14 (04) : 349 - 360